Percutaneous absorption of corticosteroids: systemic effects.
D015065:17-Hydroxycorticosteroids / Q000378:metabolism; D015068:17-Ketosteroids / Q000378:metabolism; D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000378:metabolism*; D000328:Adult; D001769:Blood; D004573:Electrolytes / Q000378:metabolism; D005260:Female; D005446:Fluocinolone Acetonide / Q000378:metabolism; D005478:Flurandrenolone / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D008297:Male; D008775:Methylprednisolone / Q000378:metabolism; D008875:Middle Aged; D010901:Pituitary Function Tests; D010912:Pituitary-Adrenal Function Tests; D011239:Prednisolone / Q000378:metabolism; D012867:Skin / Q000378:metabolism*; D012869:Skin Absorption; D012871:Skin Diseases / Q000188:drug therapy*; D014222:Triamcinolone Acetonide / Q000378:metabolism; D014556:Urine
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D004573:Electrolytes; D005446:Fluocinolone Acetonide; D005478:Flurandrenolone; D011239:Prednisolone; D014222:Triamcinolone Acetonide; D006854:Hydrocortisone; D008775:Methylprednisolone